Novo Nordisk

A healthcare company active in diabetes care, haemostasis management, growth hormone therapy and hormone replacement therapy. It manufactures and markets pharmaceutical products and services, has a headquarters in Denmark, employs 26,550 people in 80 countries, and markets its products in 179 countries. Its B shares are listed on the stock exchanges in Copenhagen and London, and its ADRs are listed on the New York Stock Exchange.